InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by VOGELBAUM MARTIN, Director. Officer active across 1 company, notably Cara Therapeutics, Inc.. Cumulatively, 6 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €111k. History available since 3 June 2021. The latest transaction was disclosed on 4 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations6 total
301,295 shares0Common StockSEC:0001415889-24-015751:0
64,724 shares0Common StockSEC:0001209191-23-034300:0
10,800 shares@ US$10.28100.0% of flowCommon StockSEC:0001209191-22-050320:0
23,752 shares0Common StockSEC:0001209191-22-034624:0
14,400 shares0Common StockSEC:0001209191-21-038766:0
14,400 shares0Common StockSEC:0001209191-21-038766
6 of 6 declarations
About VOGELBAUM MARTIN
Martin Vogelbaum is a Board Member of Cara Therapeutics, Inc. He brings valuable expertise in pharmaceutical product development. His role on the board involves guiding the company's strategic initiatives, which focus on pain management treatments.
